GINKGO BIOWORKS HOLDINGS, INC. Equity Securities, FV-NI, Gain (Loss)
GINKGO BIOWORKS HOLDINGS, INC. (DNA) reported Equity Securities, FV-NI, Gain (Loss) of -$16.41 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiGainLoss · last filed 2026-02-26
- GINKGO BIOWORKS HOLDINGS, INC. equity securities, fv-ni, gain (loss) for the quarter ending 2024-12-31 was -$7.43M.
- GINKGO BIOWORKS HOLDINGS, INC. equity securities, fv-ni, gain (loss) for the quarter ending 2024-09-30 was -$6.07M.
- GINKGO BIOWORKS HOLDINGS, INC. equity securities, fv-ni, gain (loss) for the quarter ending 2023-12-31 was -$10.01M.
- GINKGO BIOWORKS HOLDINGS, INC. equity securities, fv-ni, gain (loss) for the quarter ending 2023-09-30 was -$36.32M.
- GINKGO BIOWORKS HOLDINGS, INC. equity securities, fv-ni, gain (loss) for fiscal 2025 was -$16.41M.
- GINKGO BIOWORKS HOLDINGS, INC. equity securities, fv-ni, gain (loss) for fiscal 2024 was -$22.87M.
- GINKGO BIOWORKS HOLDINGS, INC. equity securities, fv-ni, gain (loss) for fiscal 2023 was -$54.83M.
- GINKGO BIOWORKS HOLDINGS, INC. equity securities, fv-ni, gain (loss) for fiscal 2022 was -$53.34M.
| Period end | Equity Securities, FV-NI, Gain (Loss) 3 month | Equity Securities, FV-NI, Gain (Loss) 6 month | Equity Securities, FV-NI, Gain (Loss) 9 month | Equity Securities, FV-NI, Gain (Loss) 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$16.41M 10-K · filed 2026-02-26 | |||
| 2024-12-31 | -$7.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$13.50M derived: sum of 2 quarters · filed 2026-02-26 | -$22.87M 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$6.07M 10-Q · filed 2024-11-12 | -$15.44M 10-Q · filed 2024-11-12 | ||
| 2023-12-31 | -$10.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$46.34M derived: sum of 2 quarters · filed 2026-02-26 | -$54.83M 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$36.32M 10-Q · filed 2024-11-12 | -$44.81M 10-Q · filed 2024-11-12 | ||
| 2022-12-31 | -$53.34M 10-K · filed 2025-02-25 |